Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
President Satoshi Ogiso: Leading the Way Forward | Satoshi Ogiso - President & CEO of Hino Motors
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Satoshi Ogiso is President/CEO/Chro at Hino Motors Ltd.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Adapting to Changing Tides Insights from abrdn Property Income Trust's Q2 Performance and Strategy,CEO,abrdn Property Income Trust Limited
00:10:00
Continental Gold: Pioneering Modern-Day Large-Scale Gold Mining in Colombia
00:10:00
Brenen Hofstadter of Generational Capital Markets shares insights on mergers and acquisitions, emphasizing deal structuring and advisory services on MandA.TV.
00:10:00
Tailored Investment Management and Strategic Wealth Planning | Roy Lines, Vice President, Nikulski Financial.
00:10:00
How She Got There: Venture Capital|Adina Davis,Principal,BoxGroup
00:10:00
Don't Miss Out on Growth: The Power of Investing Early | Jonathan R. Harner - Owner, Financial Advisor of Wichita Wealth Management, LLC
00:00:00
Forward looking statements about Cyclacel Pharmaceuticals, Inc. - Spiro Rombotis, President and CEO of Cyclacel Pharmaceuticals, Inc.
00:00:00
Care Options for Facial Reanimation - Elizabeth A. Bradley, M.D. Ophthalmologist, Mayo Clinic
00:10:00
Jeff Puritt, President & CEO of TELUS International, discusses the company's growth, adding 25,000 team members two years after its IPO, on NYSE Floor Talk.|Jeff Puritt, CEO of TELUS International
00:10:00
Overview of Nevada Copper and the Pumpkin Hollow Project
00:10:00
Advancing Therapeutic Solutions for Rare Diseases: Acer's Diverse Clinical Pipeline|Chris Schelling, CEO, Acer Therapeutics Inc.
00:10:00
Silver Hammer Mining Corp: Newly Formed Silver Company with Promising Past-Producing Assets